Julien Adicho, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1608 7th St Ste B, Las Vegas, NM 87701 Phone: 718-963-7332 |
Lindsy Laura Kragt Allen, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 1608 7th St, Las Vegas, NM 87701 Phone: 505-395-9575 Fax: 505-466-5166 |
Las Vegas Foot Specialist, Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 109 Railroad Ave, Las Vegas, NM 87701 Phone: 505-425-9491 Fax: 505-454-8171 |
Bruce A Andersen, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 109 Railroad Ave, Las Vegas, NM 87701 Phone: 505-425-9491 Fax: 505-454-8171 |
Dr. Alexander Ramirez, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 1608 7th St Ste B, Las Vegas, NM 87701 Phone: 505-425-3569 |
Foot And Ankle Specialists Of Northern New Mexico Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 105 Mills Ave, Ste 100, Las Vegas, NM 87701 Phone: 505-425-3569 Fax: 505-434-0042 |
News Archive
Scientists conducting one of the largest full DNA analyses of a rare disease have identified a gene mutation associated with a perplexing brain condition that blinds and paralyzes patients.
Reinforcing General Mills' on-going commitment to helping Americans achieve a healthy weight through energy balance, the company joined retailers, non-government organizations and peer food and beverage manufacturers today to launch the Healthy Weight Commitment Foundation (HWCF).
Currently, attempts to prevent spread of these infections include isolating infected patients and increasing staff hygiene measures such as handwashing. However, these attempts have met with limited success.
Pfizer Inc. announced today that the United States District Court for the District of Delaware upheld its composition of matter patent and pain and seizure use patents covering LYRICA (pregabalin) capsules CV. With this decision, Pfizer will exclusively provide pregabalin as LYRICA to patients through December 30, 2018 in the U.S., pending generic company appeal and further litigation.
› Verified 4 days ago